BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2944152)

  • 21. Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
    Graham D; Tahraoui L; Langer SZ
    Neuropharmacology; 1987 Aug; 26(8):1087-92. PubMed ID: 2958720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
    Yoshida Y
    Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H] sertraline binding to rat brain membranes.
    Koe BK; Lebel LA; Welch WM
    Psychopharmacology (Berl); 1990; 100(4):470-6. PubMed ID: 2138796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
    Andersson A; Adolfsson R; Eriksson K; Marcusson J
    Neurobiol Aging; 1991; 12(5):531-4. PubMed ID: 1837595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.
    Cortés R; Soriano E; Pazos A; Probst A; Palacios JM
    Neuroscience; 1988 Nov; 27(2):473-96. PubMed ID: 2975361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
    Segonzac A; Schoemaker H; Langer SZ
    J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium-dependent [3H]imipramine binding in rat hippocampus and its relationship to serotonin uptake.
    Hrdina PD
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2422-7. PubMed ID: 2452679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of two components of specific [3H]imipramine binding in rat brain.
    Hrdina PD
    Eur J Pharmacol; 1984 Jul; 102(3-4):481-8. PubMed ID: 6092098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pitfalls in demonstrating an endogenous ligand of imipramine recognition sites.
    Lee CR; Galzin AM; Taranger MA; Langer SZ
    Biochem Pharmacol; 1987 Mar; 36(6):945-9. PubMed ID: 3032200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
    Marcusson JO; Ross SB
    Psychopharmacology (Berl); 1990; 102(2):145-55. PubMed ID: 2274599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubilization and characterization of [3H]imipramine and [3H]paroxetine binding sites from calf striatum.
    Rotondo A; Giannaccini G; Quattrone C; Marazziti D; Martini C; Cassano GB; Lucacchini A
    Neurochem Res; 1994 Oct; 19(10):1295-300. PubMed ID: 7891847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the existence of serotonin uptake inhibitor-like substances in human cerebrospinal fluid.
    Goto S; Egashira T; Yamanaka Y
    Jpn J Pharmacol; 1991 Jul; 56(3):297-302. PubMed ID: 1832727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-hooded and Sprague Dawley rats.
    Arora RC; Tong C; Jackman HL; Stoff D; Meltzer HY
    Life Sci; 1983 Aug; 33(5):437-42. PubMed ID: 6877030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
    Lawrence KM; Falkowski J; Jacobson RR; Horton RW
    Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.
    Marcusson JO; Andersson A; Bäckström I
    Psychopharmacology (Berl); 1989; 99(1):17-21. PubMed ID: 2528778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitroimipramines - synthesis and pharmacological effects of potent long-acting inhibitors of [3H] serotonin uptake and [3H] imipramine binding.
    Rehavi M; Ittah Y; Skolnick P; Rice KC; Paul SM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):45-9. PubMed ID: 7121610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.